Genomics Market Size, Share & Trends Analysis Report By Technology & Application (Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery), By Deliverables, End Use, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Genomics Market Growth & Trends
The global genomics market size is expected to reach USD 94.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 16.4% in the forecast period owing to the increasing demand for novel therapeutic and research applications in genomics. Moreover, it is extensively used for a wide variety of applications, such as pharmacogenomics, and metagenomics. The emerging applications of genomics are braced up by industrial collaborations and expansions. For instance, in June 2020, Merck & Co., Inc., and 10x Genomics, Inc., collaborates to develop powerful genomics-based experiments to better understand the relationship between specific genes and disease by using 10x Genomics’ barcode technology to screen single cells using CRISPR libraries.
Technological advancements in the genomics market such as research on chromosomal instability and gene signatures utilizing unique samples from huge databases give out comprehensive insights into their clinical applicability. For instance, in June 2022, researchers from Cambridge University and the National Cancer Research Center (at Madrid, Spain) deduced to track chromosomal instability and copy number variations to understand the role of internal factors in driving such genomic alterations in cancers that are fatal in nature.
Diseases caused by genetic inheritance can cause a wide range of disease conditions such as cardiovascular, diabetes, and cancer conditions. Genetic disorders can be effectively combatted by understanding specific characteristics of an individual’s genome sequence. For instance, in November 2021, Illumina, Inc. and the Genetic Alliance, collectively declared the launch of the iHope genetic health program so as to facilitate access to whole-genome sequencing to survivors of genetic disorders across the globeDee with one-third of the efforts to support subjects in Africa.
The market is positively driven by the lucrative support from the government and other research organizations for advancement in research on the genome sequence. There has been an increasing focus on funds for data-driven initiatives on genome sequence research to derive outcomes that are helpful for the treatment of rare diseases, infectious diseases, inherited disorders, and cancers. For instance, in August 2022, Medical Device Innovation Consortium launched its somatic reference samples initiative to develop clinically relevant samples and public genomic datasets to aid the enhancement of NGS-based cancer diagnostics. Similarly, in September 2022, the Centres for Disease Control (CDC) declared 5-year awards to establish the pathogen genomics centers of excellence (PGCoE) network to foster innovation and capabilities in bioinformatics, pathogen genomics, and molecular epidemiology.
One of the most important factors anticipated to impact the genomics market is how much and to what extent the medical community will make use of available genomic information in personalized medicine. Furthermore, plummeting costs of sequencing support an increase in the adoption of whole genome sequencing. Scientists are combining the data generated from sequencing with diagnostics, which has proven effective in enhancing the personalized treatment landscape. According to a report published by OGL, as of July 2021, the UK exceeded 600,000 SARS-CoV-2 genomically sequenced tests. Genomic sequencing has been helpful in the fight against SARS-CoV-2 by quickly identifying variations that are of concern, elucidating how they spread, and halting them.
Genomics Market Report Highlights
Genomics Market Growth & Trends
The global genomics market size is expected to reach USD 94.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 16.4% in the forecast period owing to the increasing demand for novel therapeutic and research applications in genomics. Moreover, it is extensively used for a wide variety of applications, such as pharmacogenomics, and metagenomics. The emerging applications of genomics are braced up by industrial collaborations and expansions. For instance, in June 2020, Merck & Co., Inc., and 10x Genomics, Inc., collaborates to develop powerful genomics-based experiments to better understand the relationship between specific genes and disease by using 10x Genomics’ barcode technology to screen single cells using CRISPR libraries.
Technological advancements in the genomics market such as research on chromosomal instability and gene signatures utilizing unique samples from huge databases give out comprehensive insights into their clinical applicability. For instance, in June 2022, researchers from Cambridge University and the National Cancer Research Center (at Madrid, Spain) deduced to track chromosomal instability and copy number variations to understand the role of internal factors in driving such genomic alterations in cancers that are fatal in nature.
Diseases caused by genetic inheritance can cause a wide range of disease conditions such as cardiovascular, diabetes, and cancer conditions. Genetic disorders can be effectively combatted by understanding specific characteristics of an individual’s genome sequence. For instance, in November 2021, Illumina, Inc. and the Genetic Alliance, collectively declared the launch of the iHope genetic health program so as to facilitate access to whole-genome sequencing to survivors of genetic disorders across the globeDee with one-third of the efforts to support subjects in Africa.
The market is positively driven by the lucrative support from the government and other research organizations for advancement in research on the genome sequence. There has been an increasing focus on funds for data-driven initiatives on genome sequence research to derive outcomes that are helpful for the treatment of rare diseases, infectious diseases, inherited disorders, and cancers. For instance, in August 2022, Medical Device Innovation Consortium launched its somatic reference samples initiative to develop clinically relevant samples and public genomic datasets to aid the enhancement of NGS-based cancer diagnostics. Similarly, in September 2022, the Centres for Disease Control (CDC) declared 5-year awards to establish the pathogen genomics centers of excellence (PGCoE) network to foster innovation and capabilities in bioinformatics, pathogen genomics, and molecular epidemiology.
One of the most important factors anticipated to impact the genomics market is how much and to what extent the medical community will make use of available genomic information in personalized medicine. Furthermore, plummeting costs of sequencing support an increase in the adoption of whole genome sequencing. Scientists are combining the data generated from sequencing with diagnostics, which has proven effective in enhancing the personalized treatment landscape. According to a report published by OGL, as of July 2021, the UK exceeded 600,000 SARS-CoV-2 genomically sequenced tests. Genomic sequencing has been helpful in the fight against SARS-CoV-2 by quickly identifying variations that are of concern, elucidating how they spread, and halting them.
Genomics Market Report Highlights
- The overall growth of the genomics market is attributed to the rising dependence of novel therapeutics for genetic disorders and cancers on genomics-based understanding
- Functional genomics held the largest market share in the year 2021, owing to the demand for rising applications in diagnostics and gene therapy. Biomarker discovery is anticipated to be the fastest-growing segment in the forecast period due to rising applications of biomarkers in disease and therapeutics research
- North America dominated the market in 2021 due to the presence of key players and rising support from the government and research institutes to advance the research on Genomics in the region
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Objectives
1.6.1 Objective
1.6.2 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Genomics Market: Market Outlook
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Trends & Outlook
3.2 Trend Analysis
3.2.1 Application Trends
3.2.2 Product Trends
3.2.3 End-use Trends
3.2.4 Regional Trends
3.3 Market Segmentation & Scope
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Growing integration of genomics data into clinical workflows
3.4.1.1.1 More targeted and personalized healthcare
3.4.1.1.2 Growth of newborn genetic screening programs
3.4.1.1.3 Advancements in noninvasive cancer screening
3.4.1.1.4 Military genomics
3.4.1.2 Technological advances to facilitate genomic R&D
3.4.1.2.1 Emergence of advanced genome editing techniques
3.4.1.2.2 Integration of new data streams
3.4.1.2.3 RNA biology
3.4.1.2.4 Single-cell biology
3.4.1.3 Rising adoption of DIRECT-TO-CONSUMER genomics
3.4.1.4 Success of genetic tools in agrigenomics
3.4.1.5 Increasing participation of different companies
3.4.1.6 Increase in government role and funding in genomics
3.4.2 Market restraint analysis
3.4.2.1 Issues regarding intellectual property protection, data management, and public policies
3.4.2.2 Dearth of Public databases and personnel knowledge on machine learning algorithms
3.4.3 Opportunity analysis
3.5 Impact of COVID-19 Pandemic on Genomics Market
3.6 Penetration & Growth Prospect Mapping For End Use, 2021
3.7 Business Environment Analysis
3.7.1 Genomics Market -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.7.2 Porter’s Five Forces Analysis
3.8 Market Share Analysis
3.8.1 Company Size
3.8.2 Product portfolio
3.8.3 Strategic Initiatives
3.9 Competitive Landscape
3.9.1 Strategy Framework
3.9.2 Market Participation Categorization
3.9.2.1 New/ emerging entrants
3.9.2.2 Mature players & leaders
CHAPTER 4 APPLICATION & TECHNOLOGY BUSINESS ANALYSIS
4.1 Functional Genomics
4.1.1 Global functional genomics market, 2018 - 2030 (USD Million)
4.1.2 Real-Time PCR
4.1.2.1 Global functional genomics market for real-time PCR, 2018 - 2030 (USD Million)
4.1.3 Transfection
4.1.3.1 Global functional genomics market for transfection, 2018 - 2030 (USD Million)
4.1.3.2 SNP analysis
4.1.3.3 Global functional genomics market for SNP analysis, 2018 - 2030 (USD Million)
4.1.4 Mutational analysis
4.1.4.1 Global functional genomics market for mutational analysis, 2018 - 2030 (USD Million)
4.1.5 Microarray analysis
4.1.5.1 Global functional genomics market for microarray analysis, 2018 - 2030 (USD Million)
4.1.6 RNA interference
4.1.6.1 Global functional genomics market for RNA interference, 2018 - 2030 (USD Million)
4.2 Epigenomics
4.2.1 Global Epigenomics market, 2018 - 2030 (USD Million)
4.2.2 Bisulfite sequencing
4.2.2.1 Global epigenomics market for bisulfite sequencing, 2018 - 2030 (USD Million)
4.2.3 Microarray analysis
4.2.3.1 Global epigenomics market for microarray analysis, 2018 - 2030 (USD Million)
4.2.4 Chromatin immunoprecipitation (ChIP & ChIP-Seq)
4.2.4.1 Global epigenomics market for chromatin immunoprecipitation (ChIP & ChIP-Seq), 2018 - 2030 (USD Million)
4.2.5 Methylated DNA immunoprecipitation (MeDIP)
4.2.5.1 Global epigenomics market for methylated DNA immunoprecipitation (MeDIP), 2018 - 2030 (USD Million)
4.2.6 High Resolution Melt (HRM)
4.2.6.1 Global epigenomics market for high resolution melt (HRM), 2018 - 2030 (USD Million)
4.2.7 Chromatin accessibility assays
4.2.7.1 Global epigenomics market for chromatin accessibility assays, 2018 - 2030 (USD Million)
4.3 Pathway Analysis
4.3.1 Global pathway analysis market, 2018 - 2030 (USD Million)
4.3.2 Microarray analysis
4.3.2.1 Global pathway analysis market for microarray analysis, 2018 - 2030 (USD Million)
4.3.3 Bead-based analysis (Bio-Plex)
4.3.3.1 Global pathway analysis market for bead-based analysis, 2018 - 2030 (USD Million)
4.3.4 Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
4.3.4.1 Global pathway analysis market for proteomics tools (2-D PAGE; yeast 2-hybrid studies), 2018 - 2030 (USD Million)
4.3.5 Real-Time PCR
4.3.5.1 Global pathway analysis market for real-time PCR, 2018 - 2030 (USD Million)
4.4 Biomarker Discovery
4.4.1 Global Biomarker discovery market, 2018 - 2030 (USD Million)
4.4.2 DNA sequencing
4.4.2.1 Global biomarker discovery market for DNA sequencing, 2018 - 2030 (USD Million)
4.4.3 Microarray analysis
4.4.3.1 Global biomarker discovery market for microarray analysis, 2018 - 2030 (USD Million)
4.4.4 Real-time PCR
4.4.4.1 Global biomarker discovery market for real-time PCR, 2018 - 2030 (USD Million)
4.4.5 Mass spectrometry
4.4.5.1 Global biomarker discovery market for mass spectrometry, 2018 - 2030 (USD Million)
4.4.6 Statistical analysis
4.4.6.1 Global biomarker discovery market for statistical analysis, 2018 - 2030 (USD Million)
4.4.7 Bioinformatics
4.4.7.1 Global biomarker discovery market for bioinformatics, 2018 - 2030 (USD Million)
4.5 Others
4.5.1 Global Other applications market, 2018 - 2030 (USD Million)
CHAPTER 5 DELIVERABLES BUSINESS ANALYSIS
5.1 Genomics Market: Deliverables Movement Analysis
5.2 Products
5.2.1 Global genomics products market, 2018 - 2030 (USD Million)
5.2.2 Instruments/Systems/Softwares
5.2.2.1 Global genomics instruments/systems market, 2018 - 2030 (USD Million)
5.2.3 Consumables & Reagents
5.2.3.1 Global genomics consumables & reagents market, 2018 - 2030 (USD Million)
5.3 Services
5.3.1 Global Genomics services market, 2018 - 2030 (USD Million)
5.3.2 Core Genomic Services
5.3.2.1 Global core genomic services market, 2018 - 2030 (USD Million)
5.3.3 NGS Based Services
5.3.3.1 Global NGS based services market, 2018 - 2030 (USD Million)
5.3.4 Biomarker Translation Services
5.3.4.1 Global biomarker translation services market, 2018 - 2030 (USD Million)
5.3.5 Computational Services
5.3.5.1 Global computational services market, 2018 - 2030 (USD Million)
5.3.6 Other Services
5.3.6.1 Global other services market, 2018 - 2030 (USD Million)
CHAPTER 6 END-USE BUSINESS ANALYSIS
6.1 Genomics Market: End-use Movement Analysis
6.2 Pharmaceutical and Biotechnology Companies
6.2.1 Global genomics market for pharmaceuticals and biotechnology companies, 2018 - 2030 (Usd Million)
6.3 Hospitals and Clinics
6.3.1 Global genomics market for hospitals and clinics, 2018 - 2030 (USD Million)
6.4 Academic and Government Institutes
6.4.1 Global genomics market for academic and government institues, 2018 - 2030 (USD Million)
6.5 Clinical Research
6.5.1 Global genomics market for clinical research, 2018 - 2030 (USD Million)
6.6 Other End-users
6.6.1 Global genomics market for other end-users, 2018 - 2030 (Usd Million)
CHAPTER 7 REGIONAL BUSINESS ANALYSIS
7.1 Genomics Market: Regional Movement Analysis, 2021 & 2030
7.2 North America
7.2.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe genomics market, 2018 - 2030 (USD Million)
7.3.2 Germany
7.3.2.1 Germany genomics market, 2018 - 2030 (USD Million)
7.3.3 U.K.
7.3.3.1 U.K. genomics market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France genomics market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy genomics market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain genomics market, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific genomics market, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan genomics market, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 China genomics market, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India genomics market, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia genomics market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea genomics market, 2018 - 2030 (USD Million)
7.5 Latin America (LATAM)
7.5.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.6 Middle East and Africa (MEA)
7.6.1 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 COMPANY PROFILES
8.1 Company Profiles
8.1.1 Agilent Technologies
8.1.1.1 Company Overview
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 Strategic Initiatives
8.1.2 Beijing Genomics Institute (BGI)
8.1.2.1 Company Overview
8.1.2.1.1 Complete Genomics Incorporated
8.1.2.2 Product Benchmarking
8.1.2.3 Strategic Initiatives
8.1.3 Bio-Rad Laboratories, Inc.
8.1.3.1 Company Overview
8.1.3.1.1 GnuBIO
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 Danaher Corporation
8.1.4.1 Company Overview
8.1.4.1.1 Beckman Coulter, Inc.
8.1.4.1.2 Cepheid
8.1.4.1 Financial Performance
8.1.4.2 Product Benchmarking
8.1.4.3 Strategic Initiatives
8.1.5 F. Hoffmann-La Roche Ltd.
8.1.5.1 Company Overview
8.1.5.1.1.1 454 Life Sciences (Roche Diagnostics Corporation)
8.1.5.1.2 Genentech, Inc.
8.1.5.1.3 Foundation Medicine, Inc.
8.1.5.1.4 Ventana Medical Systems, Inc.
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Strategic Initiatives
8.1.6 Oxford Nanopore Technologies
8.1.6.1 Company Overview
8.1.6.2 Product Benchmarking
8.1.6.3 Strategic Initiatives
8.1.7 Pacific Biosciences of California, Inc.
8.1.7.1 Company Overview
8.1.7.2 Financial Performance
8.1.7.3 Product Benchmarking
8.1.7.4 Strategic Initiatives
8.1.8 Qiagen N.V.
8.1.8.1 Company Overview
8.1.8.2 Financial Performance
8.1.8.3 Product Benchmarking
8.1.8.4 Strategic Initiatives
8.1.9 Quest Diagnostics Incorporated
8.1.9.1 Company Overview
8.1.9.2 Financial Performance
8.1.9.3 Product Benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 Myriad Genetics, Inc.
8.1.10.1 Company Overview
8.1.10.2 Financial Performance
8.1.10.3 Product Benchmarking
8.1.10.4 Strategic Initiatives
8.1.11 Eppendorf AG
8.1.11.1 Company Overview
8.1.11.2 Financial Performance
8.1.11.3 Product Benchmarking
8.1.11.4 Strategic Initiatives
8.1.12 Eurofins Scientific
8.1.12.1 Company Overview
8.1.12.2 Financial Performance
8.1.12.3 Product Benchmarking
8.1.12.4 Strategic Initiatives
8.1.13 Color Health, Inc.
8.1.13.1 Company Overview
8.1.13.2 Product Benchmarking
8.1.13.3 Strategic Initiatives
8.1.14 23andMe, Inc.
8.1.14.1 Company Overview
8.1.14.2 Product Benchmarking
8.1.14.3 Strategic Initiatives
8.1.15 Thermo Fisher Scientific, Inc.
8.1.15.1 Company Overview
8.1.15.1.1 Life Technologies Corp.
8.1.15.1.2 Affymetrix
8.1.15.1.3 Applied Biosystems
8.1.15.2 Financial Performance
8.1.15.3 Product Benchmarking
8.1.15.4 Strategic Initiatives
8.1.16 GE Healthcare
8.1.16.1 Company Overview
8.1.16.2 Financial Performance
8.1.16.3 Product Benchmarking
8.1.16.4 Strategic Initiatives
8.1.17 Illumina, Inc
8.1.17.1 Company Overview
8.1.17.2 Financial Performance
8.1.17.3 Product Benchmarking
8.1.17.4 Strategic Initiatives
1.1 Research Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Objectives
1.6.1 Objective
1.6.2 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Genomics Market: Market Outlook
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Trends & Outlook
3.2 Trend Analysis
3.2.1 Application Trends
3.2.2 Product Trends
3.2.3 End-use Trends
3.2.4 Regional Trends
3.3 Market Segmentation & Scope
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Growing integration of genomics data into clinical workflows
3.4.1.1.1 More targeted and personalized healthcare
3.4.1.1.2 Growth of newborn genetic screening programs
3.4.1.1.3 Advancements in noninvasive cancer screening
3.4.1.1.4 Military genomics
3.4.1.2 Technological advances to facilitate genomic R&D
3.4.1.2.1 Emergence of advanced genome editing techniques
3.4.1.2.2 Integration of new data streams
3.4.1.2.3 RNA biology
3.4.1.2.4 Single-cell biology
3.4.1.3 Rising adoption of DIRECT-TO-CONSUMER genomics
3.4.1.4 Success of genetic tools in agrigenomics
3.4.1.5 Increasing participation of different companies
3.4.1.6 Increase in government role and funding in genomics
3.4.2 Market restraint analysis
3.4.2.1 Issues regarding intellectual property protection, data management, and public policies
3.4.2.2 Dearth of Public databases and personnel knowledge on machine learning algorithms
3.4.3 Opportunity analysis
3.5 Impact of COVID-19 Pandemic on Genomics Market
3.6 Penetration & Growth Prospect Mapping For End Use, 2021
3.7 Business Environment Analysis
3.7.1 Genomics Market -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.7.2 Porter’s Five Forces Analysis
3.8 Market Share Analysis
3.8.1 Company Size
3.8.2 Product portfolio
3.8.3 Strategic Initiatives
3.9 Competitive Landscape
3.9.1 Strategy Framework
3.9.2 Market Participation Categorization
3.9.2.1 New/ emerging entrants
3.9.2.2 Mature players & leaders
CHAPTER 4 APPLICATION & TECHNOLOGY BUSINESS ANALYSIS
4.1 Functional Genomics
4.1.1 Global functional genomics market, 2018 - 2030 (USD Million)
4.1.2 Real-Time PCR
4.1.2.1 Global functional genomics market for real-time PCR, 2018 - 2030 (USD Million)
4.1.3 Transfection
4.1.3.1 Global functional genomics market for transfection, 2018 - 2030 (USD Million)
4.1.3.2 SNP analysis
4.1.3.3 Global functional genomics market for SNP analysis, 2018 - 2030 (USD Million)
4.1.4 Mutational analysis
4.1.4.1 Global functional genomics market for mutational analysis, 2018 - 2030 (USD Million)
4.1.5 Microarray analysis
4.1.5.1 Global functional genomics market for microarray analysis, 2018 - 2030 (USD Million)
4.1.6 RNA interference
4.1.6.1 Global functional genomics market for RNA interference, 2018 - 2030 (USD Million)
4.2 Epigenomics
4.2.1 Global Epigenomics market, 2018 - 2030 (USD Million)
4.2.2 Bisulfite sequencing
4.2.2.1 Global epigenomics market for bisulfite sequencing, 2018 - 2030 (USD Million)
4.2.3 Microarray analysis
4.2.3.1 Global epigenomics market for microarray analysis, 2018 - 2030 (USD Million)
4.2.4 Chromatin immunoprecipitation (ChIP & ChIP-Seq)
4.2.4.1 Global epigenomics market for chromatin immunoprecipitation (ChIP & ChIP-Seq), 2018 - 2030 (USD Million)
4.2.5 Methylated DNA immunoprecipitation (MeDIP)
4.2.5.1 Global epigenomics market for methylated DNA immunoprecipitation (MeDIP), 2018 - 2030 (USD Million)
4.2.6 High Resolution Melt (HRM)
4.2.6.1 Global epigenomics market for high resolution melt (HRM), 2018 - 2030 (USD Million)
4.2.7 Chromatin accessibility assays
4.2.7.1 Global epigenomics market for chromatin accessibility assays, 2018 - 2030 (USD Million)
4.3 Pathway Analysis
4.3.1 Global pathway analysis market, 2018 - 2030 (USD Million)
4.3.2 Microarray analysis
4.3.2.1 Global pathway analysis market for microarray analysis, 2018 - 2030 (USD Million)
4.3.3 Bead-based analysis (Bio-Plex)
4.3.3.1 Global pathway analysis market for bead-based analysis, 2018 - 2030 (USD Million)
4.3.4 Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
4.3.4.1 Global pathway analysis market for proteomics tools (2-D PAGE; yeast 2-hybrid studies), 2018 - 2030 (USD Million)
4.3.5 Real-Time PCR
4.3.5.1 Global pathway analysis market for real-time PCR, 2018 - 2030 (USD Million)
4.4 Biomarker Discovery
4.4.1 Global Biomarker discovery market, 2018 - 2030 (USD Million)
4.4.2 DNA sequencing
4.4.2.1 Global biomarker discovery market for DNA sequencing, 2018 - 2030 (USD Million)
4.4.3 Microarray analysis
4.4.3.1 Global biomarker discovery market for microarray analysis, 2018 - 2030 (USD Million)
4.4.4 Real-time PCR
4.4.4.1 Global biomarker discovery market for real-time PCR, 2018 - 2030 (USD Million)
4.4.5 Mass spectrometry
4.4.5.1 Global biomarker discovery market for mass spectrometry, 2018 - 2030 (USD Million)
4.4.6 Statistical analysis
4.4.6.1 Global biomarker discovery market for statistical analysis, 2018 - 2030 (USD Million)
4.4.7 Bioinformatics
4.4.7.1 Global biomarker discovery market for bioinformatics, 2018 - 2030 (USD Million)
4.5 Others
4.5.1 Global Other applications market, 2018 - 2030 (USD Million)
CHAPTER 5 DELIVERABLES BUSINESS ANALYSIS
5.1 Genomics Market: Deliverables Movement Analysis
5.2 Products
5.2.1 Global genomics products market, 2018 - 2030 (USD Million)
5.2.2 Instruments/Systems/Softwares
5.2.2.1 Global genomics instruments/systems market, 2018 - 2030 (USD Million)
5.2.3 Consumables & Reagents
5.2.3.1 Global genomics consumables & reagents market, 2018 - 2030 (USD Million)
5.3 Services
5.3.1 Global Genomics services market, 2018 - 2030 (USD Million)
5.3.2 Core Genomic Services
5.3.2.1 Global core genomic services market, 2018 - 2030 (USD Million)
5.3.3 NGS Based Services
5.3.3.1 Global NGS based services market, 2018 - 2030 (USD Million)
5.3.4 Biomarker Translation Services
5.3.4.1 Global biomarker translation services market, 2018 - 2030 (USD Million)
5.3.5 Computational Services
5.3.5.1 Global computational services market, 2018 - 2030 (USD Million)
5.3.6 Other Services
5.3.6.1 Global other services market, 2018 - 2030 (USD Million)
CHAPTER 6 END-USE BUSINESS ANALYSIS
6.1 Genomics Market: End-use Movement Analysis
6.2 Pharmaceutical and Biotechnology Companies
6.2.1 Global genomics market for pharmaceuticals and biotechnology companies, 2018 - 2030 (Usd Million)
6.3 Hospitals and Clinics
6.3.1 Global genomics market for hospitals and clinics, 2018 - 2030 (USD Million)
6.4 Academic and Government Institutes
6.4.1 Global genomics market for academic and government institues, 2018 - 2030 (USD Million)
6.5 Clinical Research
6.5.1 Global genomics market for clinical research, 2018 - 2030 (USD Million)
6.6 Other End-users
6.6.1 Global genomics market for other end-users, 2018 - 2030 (Usd Million)
CHAPTER 7 REGIONAL BUSINESS ANALYSIS
7.1 Genomics Market: Regional Movement Analysis, 2021 & 2030
7.2 North America
7.2.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe genomics market, 2018 - 2030 (USD Million)
7.3.2 Germany
7.3.2.1 Germany genomics market, 2018 - 2030 (USD Million)
7.3.3 U.K.
7.3.3.1 U.K. genomics market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France genomics market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy genomics market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain genomics market, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific genomics market, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan genomics market, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 China genomics market, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India genomics market, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia genomics market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea genomics market, 2018 - 2030 (USD Million)
7.5 Latin America (LATAM)
7.5.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.6 Middle East and Africa (MEA)
7.6.1 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8 COMPANY PROFILES
8.1 Company Profiles
8.1.1 Agilent Technologies
8.1.1.1 Company Overview
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 Strategic Initiatives
8.1.2 Beijing Genomics Institute (BGI)
8.1.2.1 Company Overview
8.1.2.1.1 Complete Genomics Incorporated
8.1.2.2 Product Benchmarking
8.1.2.3 Strategic Initiatives
8.1.3 Bio-Rad Laboratories, Inc.
8.1.3.1 Company Overview
8.1.3.1.1 GnuBIO
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 Danaher Corporation
8.1.4.1 Company Overview
8.1.4.1.1 Beckman Coulter, Inc.
8.1.4.1.2 Cepheid
8.1.4.1 Financial Performance
8.1.4.2 Product Benchmarking
8.1.4.3 Strategic Initiatives
8.1.5 F. Hoffmann-La Roche Ltd.
8.1.5.1 Company Overview
8.1.5.1.1.1 454 Life Sciences (Roche Diagnostics Corporation)
8.1.5.1.2 Genentech, Inc.
8.1.5.1.3 Foundation Medicine, Inc.
8.1.5.1.4 Ventana Medical Systems, Inc.
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Strategic Initiatives
8.1.6 Oxford Nanopore Technologies
8.1.6.1 Company Overview
8.1.6.2 Product Benchmarking
8.1.6.3 Strategic Initiatives
8.1.7 Pacific Biosciences of California, Inc.
8.1.7.1 Company Overview
8.1.7.2 Financial Performance
8.1.7.3 Product Benchmarking
8.1.7.4 Strategic Initiatives
8.1.8 Qiagen N.V.
8.1.8.1 Company Overview
8.1.8.2 Financial Performance
8.1.8.3 Product Benchmarking
8.1.8.4 Strategic Initiatives
8.1.9 Quest Diagnostics Incorporated
8.1.9.1 Company Overview
8.1.9.2 Financial Performance
8.1.9.3 Product Benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 Myriad Genetics, Inc.
8.1.10.1 Company Overview
8.1.10.2 Financial Performance
8.1.10.3 Product Benchmarking
8.1.10.4 Strategic Initiatives
8.1.11 Eppendorf AG
8.1.11.1 Company Overview
8.1.11.2 Financial Performance
8.1.11.3 Product Benchmarking
8.1.11.4 Strategic Initiatives
8.1.12 Eurofins Scientific
8.1.12.1 Company Overview
8.1.12.2 Financial Performance
8.1.12.3 Product Benchmarking
8.1.12.4 Strategic Initiatives
8.1.13 Color Health, Inc.
8.1.13.1 Company Overview
8.1.13.2 Product Benchmarking
8.1.13.3 Strategic Initiatives
8.1.14 23andMe, Inc.
8.1.14.1 Company Overview
8.1.14.2 Product Benchmarking
8.1.14.3 Strategic Initiatives
8.1.15 Thermo Fisher Scientific, Inc.
8.1.15.1 Company Overview
8.1.15.1.1 Life Technologies Corp.
8.1.15.1.2 Affymetrix
8.1.15.1.3 Applied Biosystems
8.1.15.2 Financial Performance
8.1.15.3 Product Benchmarking
8.1.15.4 Strategic Initiatives
8.1.16 GE Healthcare
8.1.16.1 Company Overview
8.1.16.2 Financial Performance
8.1.16.3 Product Benchmarking
8.1.16.4 Strategic Initiatives
8.1.17 Illumina, Inc
8.1.17.1 Company Overview
8.1.17.2 Financial Performance
8.1.17.3 Product Benchmarking
8.1.17.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Incidence of Diseases
Table 4 Global Genomics Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 6 Global Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 7 Global Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 8 North America Genomics Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 10 North America Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 11 North America Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 12 U.S. Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 13 U.S. Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 14 U.S. Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 15 Canada Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 16 Canada Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 17 Canada Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 18 Europe Genomics Market, By Country, 2018 - 2030 (USD Million)
Table 19 Europe Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 20 Europe Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 21 Europe Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 22 Germany Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 23 Germany Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 24 Germany Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 25 UK Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 26 UK Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 27 UK Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 28 France Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 29 France Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 30 France Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 31 Italy Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 32 Italy Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 33 Italy Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 34 Spain Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 35 Spain Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 36 Spain Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 37 Asia Pacific Genomics Market, By Country, 2018 - 2030 (USD Million)
Table 38 Asia Pacific Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 39 Asia Pacific Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 40 Asia pacific Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 41 Japan Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 42 Japan Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 43 Japan Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 44 China Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 45 China Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 46 China Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 47 India Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 48 India Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 49 India Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 50 South Korea Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 51 South Korea Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 52 South Korea Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 53 Australia Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 54 Australia Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 55 Australia Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 56 Latin America Genomics Market, By Country, 2018 - 2030 (USD Million)
Table 57 Latin America Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 58 Latin America Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 59 Latin America Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 60 Brazil Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 61 Brazil Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 62 Brazil Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 63 Mexico Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 64 Mexico Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 65 Mexico Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 66 Argentina Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 67 Argentina Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 68 Argentina Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 69 Middle East & Africa Genomics Market, By Country, 2018 - 2030 (USD Million)
Table 70 Middle East & Africa Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 71 Middle East & Africa Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 72 Middle East & Africa Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 75 Saudi Arabia Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 76 South Africa Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 77 South Africa Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 78 South Africa Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 79 UAE Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 80 UAE Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 81 UAE Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Incidence of Diseases
Table 4 Global Genomics Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 6 Global Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 7 Global Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 8 North America Genomics Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 10 North America Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 11 North America Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 12 U.S. Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 13 U.S. Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 14 U.S. Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 15 Canada Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 16 Canada Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 17 Canada Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 18 Europe Genomics Market, By Country, 2018 - 2030 (USD Million)
Table 19 Europe Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 20 Europe Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 21 Europe Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 22 Germany Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 23 Germany Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 24 Germany Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 25 UK Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 26 UK Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 27 UK Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 28 France Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 29 France Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 30 France Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 31 Italy Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 32 Italy Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 33 Italy Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 34 Spain Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 35 Spain Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 36 Spain Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 37 Asia Pacific Genomics Market, By Country, 2018 - 2030 (USD Million)
Table 38 Asia Pacific Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 39 Asia Pacific Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 40 Asia pacific Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 41 Japan Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 42 Japan Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 43 Japan Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 44 China Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 45 China Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 46 China Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 47 India Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 48 India Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 49 India Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 50 South Korea Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 51 South Korea Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 52 South Korea Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 53 Australia Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 54 Australia Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 55 Australia Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 56 Latin America Genomics Market, By Country, 2018 - 2030 (USD Million)
Table 57 Latin America Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 58 Latin America Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 59 Latin America Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 60 Brazil Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 61 Brazil Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 62 Brazil Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 63 Mexico Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 64 Mexico Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 65 Mexico Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 66 Argentina Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 67 Argentina Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 68 Argentina Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 69 Middle East & Africa Genomics Market, By Country, 2018 - 2030 (USD Million)
Table 70 Middle East & Africa Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 71 Middle East & Africa Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 72 Middle East & Africa Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 73 Saudi Arabia Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 75 Saudi Arabia Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 76 South Africa Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 77 South Africa Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 78 South Africa Genomics Market, By End-use, 2018 - 2030 (USD Million)
Table 79 UAE Genomics Market, By Application, 2018 - 2030 (USD Million)
Table 80 UAE Genomics Market, By Deliverables, 2018 - 2030 (USD Million)
Table 81 UAE Genomics Market, By End-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market summary
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Application of human genome to personal healthcare
Fig. 12 Spinal Muscular Atrophy (SMA) prenatal screening trend in the department of defense from 2016 to July 2017
Fig. 13 Categories of tests offered by Direct-To-Consumer (DTC) companies
Fig. 14 Global impact of biotech crop adoption in 2014
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Penetration & growth prospect mapping for End-use, 2018
Fig. 17 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 18 Porter’s Five Forces Analysis
Fig. 19 Global genomics market: Deliverable outlook key takeaways
Fig. 20 Global genomics products market, 2018 - 2030 (USD Million)
Fig. 21 Global genomics services market, 2018 - 2030 (USD Million)
Fig. 22 Cost per raw megabase (Mb) of DNA sequence (USD)
Fig. 23 Cost per genome
Fig. 24 Global genomics instruments/systems/software market, 2018 - 2030 (USD Million)
Fig. 25 Global genomics consumables & reagents market, 2018 - 2030 (USD Million)
Fig. 26 Global genomics services market, 2018 - 2030 (USD Million)
Fig. 27 Global core genomics services market, 2018 - 2030 (USD Million)
Fig. 28 Global NGS based services market, 2018 - 2030 (USD Million)
Fig. 29 Global biomarker translation services market, 2018 - 2030 (USD Million)
Fig. 30 Global computational services market, 2018 - 2030 (USD Million)
Fig. 31 Global other services market, 2018 - 2030 (USD Million)
Fig. 32 Genomics market: Application & technology outlook key takeaways
Fig. 33 Global genomics market: Application & technology movement analysis
Fig. 34 Global functional genomics market, 2018 - 2030 (USD Million)
Fig. 35 Global transfection in functional genomics market, 2018 - 2030 (USD Million)
Fig. 36 Global real time PCR in functional genomics market, 2018 - 2030 (USD Million)
Fig. 37 Global RNA interference in functional genomics market, 2018 - 2030 (USD Million)
Fig. 38 Global mutational analysis in functional genomics market, 2018 - 2030 (USD Million)
Fig. 39 Global SNP analysis in functional genomics market, 2018 - 2030 (USD Million)
Fig. 40 Global microarray analysis in functional genomics market, 2018 - 2030 (USD Million)
Fig. 41 Global epigenomics market, 2018 - 2030 (USD Million)
Fig. 42 Global bisulfite sequencing in epigenomics market, 2018 - 2030 (USD Million)
Fig. 43 Global chromatin immunoprecipitation-sequencing in epigenomics market, 2018 - 2030 (USD Million)
Fig. 44 Global methylated DNA immunoprecipitation in epigenomics market, 2018 - 2030 (USD Million)
Fig. 45 Applications of HRM
Fig. 46 Global high-resolution melt in epigenomics market, 2018 - 2030 (USD Million)
Fig. 47 Global chromatin accessibility assays in epigenomics market, 2018 - 2030 (USD Million)
Fig. 48 Global microarray analysis in epigenomics market, 2018 - 2030 (USD Million)
Fig. 49 Global pathway analysis market, 2018 - 2030 (USD Million)
Fig. 50 Global bead-based analysis (Bio-Plex) for pathway analysis market, 2018 - 2030 (USD Million)
Fig. 51 Global microarray analysis in pathway analysis market, 2018 - 2030 (USD Million)
Fig. 52 Global real time PCR in pathway analysis market, 2018 - 2030 (USD Million)
Fig. 53 Global proteomics tools (2-D PAGE; yeast 2-hybrid studies) in pathway analysis market, 2018 - 2030 (USD Million)
Fig. 54 Translation of biomarker candidate in clinical practice
Fig. 55 Global biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 56 Global mass spectrometry for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 57 Global real time PCR for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 58 Global microarray analysis for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 59 Global statistical analysis for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 60 Global bioinformatics for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 61 Global DNA sequencing for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 62 Global other services market, 2018 - 2030 (USD Million)
Fig. 63 Genomics market: End-use outlook key takeaways
Fig. 64 Global genomics market: End-use movement analysis
Fig. 65 Global clinical research market, 2018 - 2030 (USD Million)
Fig. 66 Global academic and government institutes market, 2018 - 2030 (USD Million)
Fig. 67 Global hospitals and clinics market, 2018 - 2030 (USD Million)
Fig. 68 Global pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
Fig. 69 Global other end users market, 2018 - 2030 (USD Million)
Fig. 70 Regional marketplace: Key takeaway
Fig. 71 Genomics regional outlook, 2020 & 2028
Fig. 72 North America genomics market, 2018 - 2030 (USD Million)
Fig. 73 U.S. genomics market, 2018 - 2030 (USD Million)
Fig. 74 Canada genomics market, 2018 - 2030 (USD Million)
Fig. 75 Europe genomics market, 2018 - 2030 (USD Million)
Fig. 76 Germany genomics market, 2018 - 2030 (USD Million)
Fig. 77 U.K. genomics market, 2018 - 2030 (USD Million)
Fig. 78 France genomics market, 2018 - 2030 (USD Million)
Fig. 79 Italy genomics market, 2018 - 2030 (USD Million)
Fig. 80 Spain genomics market, 2018 - 2030 (USD Million)
Fig. 81 Asia Pacific genomics market, 2018 - 2030 (USD Million)
Fig. 82 Japan genomics market, 2018 - 2030 (USD Million)
Fig. 83 China genomics market, 2018 - 2030 (USD Million)
Fig. 84 India genomics market, 2018 - 2030 (USD Million)
Fig. 85 Australia genomics market, 2018 - 2030 (USD Million)
Fig. 86 South Korea genomics market, 2018 - 2030 (USD Million)
Fig. 87 Latin America genomics market, 2018 - 2030 (USD Million)
Fig. 88 Brazil genomics market, 2018 - 2030 (USD Million)
Fig. 89 Mexico genomics market, 2018 - 2030 (USD Million)
Fig. 90 MEA genomics market, 2018 - 2030 (USD Million)
Fig. 91 South Africa genomics market, 2018 - 2030 (USD Million)
Fig. 92 Saudi Arabia genomics market, 2018 - 2030 (USD Million)
Fig. 93 Strategy framework
Fig. 94 Participant categorization
Fig. 1 Market summary
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Application of human genome to personal healthcare
Fig. 12 Spinal Muscular Atrophy (SMA) prenatal screening trend in the department of defense from 2016 to July 2017
Fig. 13 Categories of tests offered by Direct-To-Consumer (DTC) companies
Fig. 14 Global impact of biotech crop adoption in 2014
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Penetration & growth prospect mapping for End-use, 2018
Fig. 17 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 18 Porter’s Five Forces Analysis
Fig. 19 Global genomics market: Deliverable outlook key takeaways
Fig. 20 Global genomics products market, 2018 - 2030 (USD Million)
Fig. 21 Global genomics services market, 2018 - 2030 (USD Million)
Fig. 22 Cost per raw megabase (Mb) of DNA sequence (USD)
Fig. 23 Cost per genome
Fig. 24 Global genomics instruments/systems/software market, 2018 - 2030 (USD Million)
Fig. 25 Global genomics consumables & reagents market, 2018 - 2030 (USD Million)
Fig. 26 Global genomics services market, 2018 - 2030 (USD Million)
Fig. 27 Global core genomics services market, 2018 - 2030 (USD Million)
Fig. 28 Global NGS based services market, 2018 - 2030 (USD Million)
Fig. 29 Global biomarker translation services market, 2018 - 2030 (USD Million)
Fig. 30 Global computational services market, 2018 - 2030 (USD Million)
Fig. 31 Global other services market, 2018 - 2030 (USD Million)
Fig. 32 Genomics market: Application & technology outlook key takeaways
Fig. 33 Global genomics market: Application & technology movement analysis
Fig. 34 Global functional genomics market, 2018 - 2030 (USD Million)
Fig. 35 Global transfection in functional genomics market, 2018 - 2030 (USD Million)
Fig. 36 Global real time PCR in functional genomics market, 2018 - 2030 (USD Million)
Fig. 37 Global RNA interference in functional genomics market, 2018 - 2030 (USD Million)
Fig. 38 Global mutational analysis in functional genomics market, 2018 - 2030 (USD Million)
Fig. 39 Global SNP analysis in functional genomics market, 2018 - 2030 (USD Million)
Fig. 40 Global microarray analysis in functional genomics market, 2018 - 2030 (USD Million)
Fig. 41 Global epigenomics market, 2018 - 2030 (USD Million)
Fig. 42 Global bisulfite sequencing in epigenomics market, 2018 - 2030 (USD Million)
Fig. 43 Global chromatin immunoprecipitation-sequencing in epigenomics market, 2018 - 2030 (USD Million)
Fig. 44 Global methylated DNA immunoprecipitation in epigenomics market, 2018 - 2030 (USD Million)
Fig. 45 Applications of HRM
Fig. 46 Global high-resolution melt in epigenomics market, 2018 - 2030 (USD Million)
Fig. 47 Global chromatin accessibility assays in epigenomics market, 2018 - 2030 (USD Million)
Fig. 48 Global microarray analysis in epigenomics market, 2018 - 2030 (USD Million)
Fig. 49 Global pathway analysis market, 2018 - 2030 (USD Million)
Fig. 50 Global bead-based analysis (Bio-Plex) for pathway analysis market, 2018 - 2030 (USD Million)
Fig. 51 Global microarray analysis in pathway analysis market, 2018 - 2030 (USD Million)
Fig. 52 Global real time PCR in pathway analysis market, 2018 - 2030 (USD Million)
Fig. 53 Global proteomics tools (2-D PAGE; yeast 2-hybrid studies) in pathway analysis market, 2018 - 2030 (USD Million)
Fig. 54 Translation of biomarker candidate in clinical practice
Fig. 55 Global biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 56 Global mass spectrometry for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 57 Global real time PCR for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 58 Global microarray analysis for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 59 Global statistical analysis for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 60 Global bioinformatics for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 61 Global DNA sequencing for biomarker discovery market, 2018 - 2030 (USD Million)
Fig. 62 Global other services market, 2018 - 2030 (USD Million)
Fig. 63 Genomics market: End-use outlook key takeaways
Fig. 64 Global genomics market: End-use movement analysis
Fig. 65 Global clinical research market, 2018 - 2030 (USD Million)
Fig. 66 Global academic and government institutes market, 2018 - 2030 (USD Million)
Fig. 67 Global hospitals and clinics market, 2018 - 2030 (USD Million)
Fig. 68 Global pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
Fig. 69 Global other end users market, 2018 - 2030 (USD Million)
Fig. 70 Regional marketplace: Key takeaway
Fig. 71 Genomics regional outlook, 2020 & 2028
Fig. 72 North America genomics market, 2018 - 2030 (USD Million)
Fig. 73 U.S. genomics market, 2018 - 2030 (USD Million)
Fig. 74 Canada genomics market, 2018 - 2030 (USD Million)
Fig. 75 Europe genomics market, 2018 - 2030 (USD Million)
Fig. 76 Germany genomics market, 2018 - 2030 (USD Million)
Fig. 77 U.K. genomics market, 2018 - 2030 (USD Million)
Fig. 78 France genomics market, 2018 - 2030 (USD Million)
Fig. 79 Italy genomics market, 2018 - 2030 (USD Million)
Fig. 80 Spain genomics market, 2018 - 2030 (USD Million)
Fig. 81 Asia Pacific genomics market, 2018 - 2030 (USD Million)
Fig. 82 Japan genomics market, 2018 - 2030 (USD Million)
Fig. 83 China genomics market, 2018 - 2030 (USD Million)
Fig. 84 India genomics market, 2018 - 2030 (USD Million)
Fig. 85 Australia genomics market, 2018 - 2030 (USD Million)
Fig. 86 South Korea genomics market, 2018 - 2030 (USD Million)
Fig. 87 Latin America genomics market, 2018 - 2030 (USD Million)
Fig. 88 Brazil genomics market, 2018 - 2030 (USD Million)
Fig. 89 Mexico genomics market, 2018 - 2030 (USD Million)
Fig. 90 MEA genomics market, 2018 - 2030 (USD Million)
Fig. 91 South Africa genomics market, 2018 - 2030 (USD Million)
Fig. 92 Saudi Arabia genomics market, 2018 - 2030 (USD Million)
Fig. 93 Strategy framework
Fig. 94 Participant categorization
